Auryxia (Ferric Citrate) Therapy for In-Center and Home Dialysis Participants

Exclusion Criteria

• •1. A known allergy or intolerance to Auryxia or any of its constituents.
• •2. Hypersensitivity reaction to previous oral iron therapy.
• •3. History of hemochromatosis or other iron overload syndrome.
• •4. Active malignancy requiring current treatment except for non-melanoma skin cancer regardless of treatment.
• •5. Active drug or alcohol dependence or abuse (excluding tobacco use or medicinal or recreational marijuana) within the 12 months prior to Screening or evidence of such abuse (in the opinion of the Investigator).
• •6. Limited life expectancy (less than 6 months), (in the opinion of the Investigator).
• •7. Scheduled organ transplant and participants on the kidney transplant wait-list who are expected to receive a transplant within 6 months of screening. Being active on transplant list is not an exclusion. Previous kidney transplant is not an exclusion.
• •8. Unable to comply with study requirements or in the opinion of the Investigator not clinically stable to participate in the study.
• •9. Females who are known to be pregnant or are breast-feeding during Screening or are planning to become pregnant and breastfeeding during the study period.
• •10. Evidence of clinically active infection at the time of Screening.
• •11. Use of an investigational medication or participation in an investigational study within 30 days prior to Screening.